title: Cerebral ischemia, matrix metalloproteinases, and TNF-alpha: MMP inhibitors may act not exclusively by reducing MMP activity.
authors.forename: Michael
authors.initials: M
authors.lastname: Dittmar
authors.forename: Georgios
authors.initials: G
authors.lastname: Kiourkenidis
authors.forename: Markus
authors.initials: M
authors.lastname: Horn
authors.forename: Susanne
authors.initials: S
authors.lastname: Bollwein
authors.forename: Günther
authors.initials: G
authors.lastname: Bernhardt
mesh_terms: D051722:ADAM Proteins; D000072198:ADAM17 Protein; D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000201:enzymology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D061965:Matrix Metalloproteinase Inhibitors; D008666:Metalloendopeptidases / Q000378:metabolism; D023421:Models, Animal; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D061965:Matrix Metalloproteinase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000072198:ADAM17 Protein